fructose-1,6-diphosphate has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, T; Hagisawa, Y; Izumi, M; Ohsumi, J; Okuno, A; Takahashi, K; Yoshida, T | 1 |
| Dai, DZ; Dai, Y; Liu, HR; Tang, XY; Ying, HJ; Zhang, Q | 1 |
2 other study(ies) available for fructose-1,6-diphosphate and Hyperglycemia
| Article | Year |
|---|---|
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Topics: Alanine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Fructose-Bisphosphatase; Fructosediphosphates; Fructosephosphates; Gluconeogenesis; Hyperglycemia; Liver; Male; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Wistar | 2008 |
Strontium fructose 1,6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated rats.
Topics: Acid Phosphatase; Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Fructosediphosphates; gamma-Glutamyltransferase; Gene Expression; Hyperglycemia; Hypogonadism; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Succinate Dehydrogenase; Testis; Testosterone; Tissue Inhibitor of Metalloproteinases | 2009 |